Christine Ring, a chief legal officer at Nurix Therapeutics, Inc., sells $103,986 of stock

Christine Ring sold $103,986 of Nurix Therapeutics, Inc. (NRIX) stock on Oct 30, according to an SEC filing. The chief legal officer received an average of $26.28 for 3,957 shares.

The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. After the trade, the filing lists 15,335 shares held.

The filing came 3 days after the trade.

Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.

The sale

Company	Nurix Therapeutics, Inc. (NRIX)
Insider	Christine Ring
Role	Chief Legal Officer
Transaction	Open-market sale (code S)
Shares	3,957
Average price	$26.28
Value	$103,986
Trade date	Oct 30, 2026
Filed with the SEC	Nov 2, 2026, 7:44 PM ET
Shares held after	15,335
Ownership	Direct
Rule 10b5-1 plan	Not marked in the filing

See every transaction in this Nurix Therapeutics, Inc. filing

View the Form 4 on SEC.gov

Follow NRIX for the next insider trade · See all the latest insider trades

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.